IBDEI217 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
 ;;=4^H35.373
 ;;^UTILITY(U,$J,358.3,32424,2)
 ;;=^5005664
 ;;^UTILITY(U,$J,358.3,32425,0)
 ;;=H35.33^^128^1660^22
 ;;^UTILITY(U,$J,358.3,32425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
 ;;=3^Angioid Streaks of Macula
 ;;^UTILITY(U,$J,358.3,32425,1,4,0)
 ;;=4^H35.33
 ;;^UTILITY(U,$J,358.3,32425,2)
 ;;=^5005649
 ;;^UTILITY(U,$J,358.3,32426,0)
 ;;=H35.711^^128^1660^7
 ;;^UTILITY(U,$J,358.3,32426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32426,1,3,0)
 ;;=3^Central Serous Chorioretinopathy,OD
 ;;^UTILITY(U,$J,358.3,32426,1,4,0)
 ;;=4^H35.711
 ;;^UTILITY(U,$J,358.3,32426,2)
 ;;=^5005703
 ;;^UTILITY(U,$J,358.3,32427,0)
 ;;=H35.712^^128^1660^8
 ;;^UTILITY(U,$J,358.3,32427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32427,1,3,0)
 ;;=3^Central Serous Chorioretinopathy,OS
 ;;^UTILITY(U,$J,358.3,32427,1,4,0)
 ;;=4^H35.712
 ;;^UTILITY(U,$J,358.3,32427,2)
 ;;=^5005704
 ;;^UTILITY(U,$J,358.3,32428,0)
 ;;=H35.713^^128^1660^9
 ;;^UTILITY(U,$J,358.3,32428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32428,1,3,0)
 ;;=3^Central Serous Chorioretinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,32428,1,4,0)
 ;;=4^H35.713
 ;;^UTILITY(U,$J,358.3,32428,2)
 ;;=^5005705
 ;;^UTILITY(U,$J,358.3,32429,0)
 ;;=H35.421^^128^1660^19
 ;;^UTILITY(U,$J,358.3,32429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32429,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,OD
 ;;^UTILITY(U,$J,358.3,32429,1,4,0)
 ;;=4^H35.421
 ;;^UTILITY(U,$J,358.3,32429,2)
 ;;=^5005675
 ;;^UTILITY(U,$J,358.3,32430,0)
 ;;=H35.422^^128^1660^20
 ;;^UTILITY(U,$J,358.3,32430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32430,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,OS
 ;;^UTILITY(U,$J,358.3,32430,1,4,0)
 ;;=4^H35.422
 ;;^UTILITY(U,$J,358.3,32430,2)
 ;;=^5005676
 ;;^UTILITY(U,$J,358.3,32431,0)
 ;;=H35.423^^128^1660^21
 ;;^UTILITY(U,$J,358.3,32431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32431,1,3,0)
 ;;=3^Microcystoid Degeneration or Retina,Bilateral
 ;;^UTILITY(U,$J,358.3,32431,1,4,0)
 ;;=4^H35.423
 ;;^UTILITY(U,$J,358.3,32431,2)
 ;;=^5005677
 ;;^UTILITY(U,$J,358.3,32432,0)
 ;;=H35.451^^128^1660^23
 ;;^UTILITY(U,$J,358.3,32432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32432,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,OD
 ;;^UTILITY(U,$J,358.3,32432,1,4,0)
 ;;=4^H35.451
 ;;^UTILITY(U,$J,358.3,32432,2)
 ;;=^5005687
 ;;^UTILITY(U,$J,358.3,32433,0)
 ;;=H35.452^^128^1660^24
 ;;^UTILITY(U,$J,358.3,32433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32433,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,OS
 ;;^UTILITY(U,$J,358.3,32433,1,4,0)
 ;;=4^H35.452
 ;;^UTILITY(U,$J,358.3,32433,2)
 ;;=^5005688
 ;;^UTILITY(U,$J,358.3,32434,0)
 ;;=H35.453^^128^1660^25
 ;;^UTILITY(U,$J,358.3,32434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32434,1,3,0)
 ;;=3^Secondary Pigmentary Degeneration,Bilateral
 ;;^UTILITY(U,$J,358.3,32434,1,4,0)
 ;;=4^H35.453
 ;;^UTILITY(U,$J,358.3,32434,2)
 ;;=^5005689
 ;;^UTILITY(U,$J,358.3,32435,0)
 ;;=H35.381^^128^1660^16
 ;;^UTILITY(U,$J,358.3,32435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32435,1,3,0)
 ;;=3^Toxic Maculopathy,OD
 ;;^UTILITY(U,$J,358.3,32435,1,4,0)
 ;;=4^H35.381
 ;;^UTILITY(U,$J,358.3,32435,2)
 ;;=^5005666
 ;;^UTILITY(U,$J,358.3,32436,0)
 ;;=H35.382^^128^1660^17
 ;;^UTILITY(U,$J,358.3,32436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32436,1,3,0)
 ;;=3^Toxic Maculopathy,OS
